Cargando…

Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology

This chapter describes the use of several of the recombinant vaccinia expression systems, focuses on the systems that are most useful for cell biologists, and discusses their advantages and limitations. Vaccinia-mediated expression can be used for assessing cellular localization, posttranslational m...

Descripción completa

Detalles Bibliográficos
Autores principales: Weisz, Ora A., Machamer, Carolyn E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press Inc. Published by Elsevier Inc. 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130382/
https://www.ncbi.nlm.nih.gov/pubmed/7823860
http://dx.doi.org/10.1016/S0091-679X(08)60602-0
_version_ 1783516998667337728
author Weisz, Ora A.
Machamer, Carolyn E.
author_facet Weisz, Ora A.
Machamer, Carolyn E.
author_sort Weisz, Ora A.
collection PubMed
description This chapter describes the use of several of the recombinant vaccinia expression systems, focuses on the systems that are most useful for cell biologists, and discusses their advantages and limitations. Vaccinia-mediated expression can be used for assessing cellular localization, posttranslational modifications, oligomerization, and transport and turnover rates. The system provides a rapid method for screening mutant proteins for expression and targeting. It is an excellent way of quickly deciding which mutant proteins might be worth further studying using stable expression systems. Expression of foreign genes using Vaccinia virus is based on recombinant viruses constructed by insertion of complementary DNA (cDNA) into the nonessential thymidine kinase (TK) gene. Both direct and indirect methods of expression are possible. The foreign gene can be inserted into the vaccinia genome by homologous recombination using a plasmid with flanking regions of vaccinia DNA. The recombinant virus is selected, expanded, and used to infect cells, which then express high levels of the foreign protein. Recombinant vaccinia viruses are generated by subcloning the foreign gene into a plasmid transfer vector so it is flanked by DNA from the vaccinia (TK) gene, which is nonessential for growth of the virus in tissue culture. This plasmid is then transfected into vaccinia-infected cells. Homologous recombination of the plasmid and the vaccinia genome generates a recombinant virus with an inactive TK gene.
format Online
Article
Text
id pubmed-7130382
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Academic Press Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71303822020-04-08 Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology Weisz, Ora A. Machamer, Carolyn E. Methods Cell Biol Article This chapter describes the use of several of the recombinant vaccinia expression systems, focuses on the systems that are most useful for cell biologists, and discusses their advantages and limitations. Vaccinia-mediated expression can be used for assessing cellular localization, posttranslational modifications, oligomerization, and transport and turnover rates. The system provides a rapid method for screening mutant proteins for expression and targeting. It is an excellent way of quickly deciding which mutant proteins might be worth further studying using stable expression systems. Expression of foreign genes using Vaccinia virus is based on recombinant viruses constructed by insertion of complementary DNA (cDNA) into the nonessential thymidine kinase (TK) gene. Both direct and indirect methods of expression are possible. The foreign gene can be inserted into the vaccinia genome by homologous recombination using a plasmid with flanking regions of vaccinia DNA. The recombinant virus is selected, expanded, and used to infect cells, which then express high levels of the foreign protein. Recombinant vaccinia viruses are generated by subcloning the foreign gene into a plasmid transfer vector so it is flanked by DNA from the vaccinia (TK) gene, which is nonessential for growth of the virus in tissue culture. This plasmid is then transfected into vaccinia-infected cells. Homologous recombination of the plasmid and the vaccinia genome generates a recombinant virus with an inactive TK gene. Academic Press Inc. Published by Elsevier Inc. 1994 2008-02-28 /pmc/articles/PMC7130382/ /pubmed/7823860 http://dx.doi.org/10.1016/S0091-679X(08)60602-0 Text en © 1994 Academic Press Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Weisz, Ora A.
Machamer, Carolyn E.
Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
title Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
title_full Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
title_fullStr Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
title_full_unstemmed Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
title_short Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
title_sort chapter 7 use of recombinant vaccinia virus vectors for cell biology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130382/
https://www.ncbi.nlm.nih.gov/pubmed/7823860
http://dx.doi.org/10.1016/S0091-679X(08)60602-0
work_keys_str_mv AT weiszoraa chapter7useofrecombinantvacciniavirusvectorsforcellbiology
AT machamercarolyne chapter7useofrecombinantvacciniavirusvectorsforcellbiology